Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2017
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network settingI Ray-Coquard, AnnaLisa Trama, M J Seckl, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 14, 2026
Particle Beam Re-irradiation in Oligo Recurrent Gynecological MalignanciesA Barcellini, A Vai, G Fontana, et al.
Gynecologic Oncology|November 4, 2019
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trialD Lorusso, G Ferrandina, N Colombo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2024
Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 studyD Lorusso, N Colombo, C Dubot, et al.
Gynecologic Oncology|June 14, 2019
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Cormio, G Ferrandina, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2018
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Ferrandina, M Candiani, et al.
Gynecologic Oncology|May 11, 2023
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancerI Vergote, E Van Nieuwenhuysen, A Casado, et al.
ESMO Open|February 26, 2026
Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trialL Paracchini, A Velle, P Di Gennaro, et al.
ESMO Open|December 6, 2025
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trialM Bartoletti, A Passarelli, A Fagotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2021
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD IK N Moore, A M Oza, N Colombo, et al.
Pageof 15